Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Raj Beri was removed as Chief Operating Officer at GoodRx Holdings, Inc..
- Action
- removed
- Role
- Chief Operating Officer
Exact text from the filing
As previously disclosed, on January 16, 2024, the Company determined that the role currently held by Raj Beri, the Company's Chief Operating Officer, would be eliminated and the Company’s Board of Directors removed Mr. Beri as Chief Operating Officer, effective as of February 15, 2024 (the “Separation Date”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
GoodRx Holdings, Inc. entered into Fifth Amendment to First Lien Credit Agreement with Barclays Bank PLC, as administrative agent, and the lenders and other parties party thereto (effective 2024-02-20).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Barclays Bank PLC, as administrative agent, and the lenders and other parties party thereto
- Effective
- 2024-02-20
Exact text from the filing
On February 20, 2024, GoodRx, Inc. (“GoodRx”), an indirect wholly-owned subsidiary of GoodRx Holdings, Inc. (the “Company”), entered into the Fifth Amendment to First Lien Credit Agreement (the “Fifth Amendment”), by and among GoodRx, as borrower, GoodRx Intermediate Holdings, LLC and the other guarantors party thereto (collectively, together with GoodRx, the “Loan Parties”), Barclays Bank PLC, as administrative agent, and the lenders and other parties party thereto, in order to amend its First Lien Credit Agreement, dated as of October 12, 2018 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), to, among other things, extend the maturity date of its $100.0 million revolving credit facility thereunder from October 11, 2024 to July 11, 2025.
View on SEC.gov